⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL491558 | 0.85 | — | — | |
| SCHEMBL206161 | 0.78 | — | — | |
| SCHEMBL1637718 | 0.74 | — | — | |
| SCHEMBL455963 | 0.74 | — | — | |
| SCHEMBL1401619 | 0.74 | — | — | |
| SCHEMBL698051 | 0.69 | NT5E (0.30) | — | |
| SCHEMBL491417 | 0.67 | — | — | |
| SCHEMBL491540 | 0.67 | — | — | |
| SCHEMBL9465594 | 0.67 | — | — | |
| SCHEMBL147215 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562799-B1 | ETHYLENE OLIGOMERIZATION PROCESSES | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-110099884-B | Ethylene oligomerization process | 切弗朗菲利浦化学公司 | 2022-03-15 | — | — | CN | disclosed |
| US-10793489-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2020-10-06 | — | — | US | disclosed |
| US-20200095178-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2020-03-26 | — | — | US | disclosed |
| US-10544070-B2 | Ethylene oligomerization process | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2020-01-28 | — | — | US | disclosed |
| EP-3562799-A1 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2019-11-06 | — | — | EP | disclosed |
| US-20190276377-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-09-12 | — | — | US | disclosed |
| US-10407360-B2 | Ethylene oligomerization processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2019-09-10 | — | — | US | disclosed |
| CN-110099884-A | Ethylene oligomerisation processes | 切弗朗菲利浦化学公司 | 2019-08-06 | — | — | CN | disclosed |
| US-20190194089-A1 | Ethylene Oligomerization Processes | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2019-06-27 | — | — | US | disclosed |
| WO-2005066178-A1 | TRIAZA-CYCLOPENTA[CD]INDENE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005066142-A2 | PYRROLOPYRIMIDINE AND PYRROLOTRIAZINE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-07-21 | — | — | WO | disclosed |
| US-6852732-B2 | Tetrahydropyridino or piperidino heterocylic derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-02-08 | — | — | US | disclosed |
| US-20050009874-A1 | Tetrahydropyridin or piperidino heterocyclic derivatives | TAISHO PHARMACEUTICAL CO., LTD. | 2005-01-13 | — | — | US | disclosed |
| EP-1467997-A1 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-20 | — | — | EP | disclosed |
| WO-2004058767-A1 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-07-15 | — | — | WO | disclosed |
| US-20040034061-A1 | Tetrahydropyridino or piperidino heterocylic derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-1299378-A4 | TETRAHYDROPYRIDINO OR PIPERIDINO HETEROCYCLIC DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2004-01-28 | — | — | EP | disclosed |
| EP-1299378-A1 | TETRAHYDROPYRIDINO OR PIPERIDINO HETEROCYCLIC DERIVATIVES | Taisho Pharmaceutical Co. Ltd. (JP) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002002549-A1 | TETRAHYDROPYRIDINO OR PIPERIDINO HETEROCYCLIC DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-01-10 | — | — | WO | disclosed |